Kostensensible Leitlinien

Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation decisions...

Descripció completa

Guardat en:
Dades bibliogràfiques
Format: Online
Idioma:alemany
Publicat: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 2021
Matèries:
Accés en línia:OCN: 1163846333
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
_version_ 1869520578462875648
collection Directory of Open Access Books
description Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation decisions should be based on clearly defined procedures and criteria. So far, however, there are no concrete approaches on how this explicit performance control can be implemented in practice. The book provides an overview of the results of the interdisciplinary research association ""Allocation"", which for the first time examined the possibilities and limits of explicit performance management in two selected practical areas (interventional cardiology and intensive care medicine). Two exemplary cost-sensitive guidelines have been developed that enable an evidence-based balance between efficiency and justice. The legal requirements for such an explicit benefit management in statutory health insurance were examined in detail. Healthcare professionals and patients were asked for their assessments of the strengths and weaknesses of the cost-sensitive guidelines.
format Online
id doab-20.500.12854ir-26200
institution Directory of Open Access Books
language ger
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
publisherStr MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
record_format ojs
spelling doab-20.500.12854ir-262002025-07-30T08:58:58Z Kostensensible Leitlinien Marckmann, Georg cost sensitivity assessment of benefit scarcity of capital evidence based medicine prioritization thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine Medical innovations and demographic change will further exacerbate the financial situation in the German healthcare system in the coming years. The evidence-based allocation of the limited funds available will therefore become increasingly important. From an ethical perspective, allocation decisions should be based on clearly defined procedures and criteria. So far, however, there are no concrete approaches on how this explicit performance control can be implemented in practice. The book provides an overview of the results of the interdisciplinary research association ""Allocation"", which for the first time examined the possibilities and limits of explicit performance management in two selected practical areas (interventional cardiology and intensive care medicine). Two exemplary cost-sensitive guidelines have been developed that enable an evidence-based balance between efficiency and justice. The legal requirements for such an explicit benefit management in statutory health insurance were examined in detail. Healthcare professionals and patients were asked for their assessments of the strengths and weaknesses of the cost-sensitive guidelines. 2021-02-10T13:00:27Z 2021-02-10T13:00:27Z 2020-06-18T10:03:50Z 2015 book OCN: 1163846333 http://library.oapen.org/handle/20.500.12657/39724 9783954664580 https://directory.doabooks.org/handle/20.500.12854/26200 ger open access image/jpeg image/jpeg image/jpeg image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International Attribution-NonCommercial-NoDerivatives 4.0 International Attribution-NonCommercial-NoDerivatives 4.0 International Attribution-NonCommercial-NoDerivatives 4.0 International https://library.oapen.org/bitstream/20.500.12657/39724/2/kostensensible-leitlinien.pdf https://library.oapen.org/bitstream/20.500.12657/39724/2/kostensensible-leitlinien.pdf https://library.oapen.org/bitstream/20.500.12657/39724/2/kostensensible-leitlinien.pdf https://library.oapen.org/bitstream/20.500.12657/39724/2/kostensensible-leitlinien.pdf MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 10.32745/9783954664580-2 10.32745/9783954664580-2 c40cfce7-9c58-4afe-a0f0-974d0995578e 9783954664580 Knowledge Unlatched (KU) 209 Berlin open access
spellingShingle cost sensitivity
assessment of benefit
scarcity of capital
evidence based medicine
prioritization
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
Kostensensible Leitlinien
title Kostensensible Leitlinien
title_full Kostensensible Leitlinien
title_fullStr Kostensensible Leitlinien
title_full_unstemmed Kostensensible Leitlinien
title_short Kostensensible Leitlinien
title_sort kostensensible leitlinien
topic cost sensitivity
assessment of benefit
scarcity of capital
evidence based medicine
prioritization
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
topic_facet cost sensitivity
assessment of benefit
scarcity of capital
evidence based medicine
prioritization
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
url OCN: 1163846333